ADMA
Price
$17.75
Change
-$0.53 (-2.90%)
Updated
Jan 15, 11:08 AM (EDT)
Capitalization
4.35B
63 days until earnings call
Intraday BUY SELL Signals
IKT
Price
$1.67
Change
-$0.03 (-1.76%)
Updated
Jan 15, 11:38 AM (EDT)
Capitalization
205.55M
Intraday BUY SELL Signals
Interact to see
Advertisement

ADMA vs IKT

Header iconADMA vs IKT Comparison
Open Charts ADMA vs IKTBanner chart's image
ADMA Biologics
Price$17.75
Change-$0.53 (-2.90%)
Volume$500
Capitalization4.35B
Inhibikase Therapeutics
Price$1.67
Change-$0.03 (-1.76%)
Volume$24.98K
Capitalization205.55M
ADMA vs IKT Comparison Chart in %
View a ticker or compare two or three
VS
ADMA vs. IKT commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADMA is a Hold and IKT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (ADMA: $18.28 vs. IKT: $1.70)
Brand notoriety: ADMA and IKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADMA: 63% vs. IKT: 35%
Market capitalization -- ADMA: $4.35B vs. IKT: $205.55M
ADMA [@Biotechnology] is valued at $4.35B. IKT’s [@Biotechnology] market capitalization is $205.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADMA’s FA Score shows that 2 FA rating(s) are green whileIKT’s FA Score has 0 green FA rating(s).

  • ADMA’s FA Score: 2 green, 3 red.
  • IKT’s FA Score: 0 green, 5 red.
According to our system of comparison, both ADMA and IKT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADMA’s TA Score shows that 4 TA indicator(s) are bullish while IKT’s TA Score has 5 bullish TA indicator(s).

  • ADMA’s TA Score: 4 bullish, 5 bearish.
  • IKT’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, IKT is a better buy in the short-term than ADMA.

Price Growth

ADMA (@Biotechnology) experienced а -2.87% price change this week, while IKT (@Biotechnology) price change was -10.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.23%. For the same industry, the average monthly price growth was +2.54%, and the average quarterly price growth was +43.40%.

Reported Earning Dates

ADMA is expected to report earnings on Mar 19, 2026.

Industries' Descriptions

@Biotechnology (-0.23% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ADMA($4.35B) has a higher market cap than IKT($206M). ADMA has higher P/E ratio than IKT: ADMA (21.26) vs IKT (3.61). ADMA YTD gains are higher at: 0.219 vs. IKT (-17.073). ADMA has higher annual earnings (EBITDA): 172M vs. IKT (-53.08M). IKT has more cash in the bank: 77.3M vs. ADMA (61.4M). IKT has less debt than ADMA: IKT (0) vs ADMA (83.1M). ADMA has higher revenues than IKT: ADMA (489M) vs IKT (0).
ADMAIKTADMA / IKT
Capitalization4.35B206M2,112%
EBITDA172M-53.08M-324%
Gain YTD0.219-17.073-1%
P/E Ratio21.263.61589%
Revenue489M0-
Total Cash61.4M77.3M79%
Total Debt83.1M0-
FUNDAMENTALS RATINGS
ADMA: Fundamental Ratings
ADMA
OUTLOOK RATING
1..100
53
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
32
SMR RATING
1..100
17
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADMAIKT
RSI
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 9 days ago
86%
Bullish Trend 16 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
ADMA
Daily Signal:
Gain/Loss:
IKT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HWMIX61.510.69
+1.13%
Hotchkis & Wiley Mid-Cap Value I
LVOSX18.840.06
+0.32%
Lord Abbett Value Opportunities R4
OIEPX24.850.08
+0.32%
JPMorgan Equity Income R3
MRLRX19.92-0.14
-0.70%
BlackRock Advantage Large Cap Core R
TPYYX8.59-0.10
-1.15%
Touchstone Sands Capital Intl Gr Eq Y

ADMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADMA has been loosely correlated with VIR. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ADMA jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADMA
1D Price
Change %
ADMA100%
+3.28%
VIR - ADMA
50%
Loosely correlated
+8.08%
CPRX - ADMA
42%
Loosely correlated
+3.67%
IMTX - ADMA
40%
Loosely correlated
+4.80%
RGNX - ADMA
40%
Loosely correlated
-0.66%
AUPH - ADMA
39%
Loosely correlated
+1.60%
More

IKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, IKT has been loosely correlated with SNDX. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if IKT jumps, then SNDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IKT
1D Price
Change %
IKT100%
+1.19%
SNDX - IKT
34%
Loosely correlated
+4.74%
ADMA - IKT
31%
Poorly correlated
+3.28%
SYRE - IKT
30%
Poorly correlated
+5.17%
SLDB - IKT
29%
Poorly correlated
+12.60%
XNCR - IKT
29%
Poorly correlated
+3.66%
More